Annual CFO
-$25.60 M
-$30.51 M-620.61%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual cash flow from operations is -$25.60 million, with the most recent change of -$30.51 million (-620.61%) on December 31, 2023.
- During the last 3 years, CAPR annual CFO has fallen by -$15.54 million (-154.57%).
- CAPR annual CFO is now -620.61% below its all-time high of $4.92 million, reached on December 31, 2022.
Performance
CAPR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$11.64 M
+$646.00 K+5.26%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly cash flow from operations is -$11.64 million, with the most recent change of +$646.00 thousand (+5.26%) on September 30, 2024.
- Over the past year, CAPR quarterly CFO has increased by +$646.00 thousand (+5.26%).
- CAPR quarterly CFO is now -148.42% below its all-time high of $24.05 million, reached on March 31, 2022.
Performance
CAPR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$36.79 M
-$2.85 M-8.39%
September 30, 2024
Summary
- As of February 7, 2025, CAPR TTM cash flow from operations is -$36.79 million, with the most recent change of -$2.85 million (-8.39%) on September 30, 2024.
- Over the past year, CAPR TTM CFO has dropped by -$2.85 million (-8.39%).
- CAPR TTM CFO is now -448.20% below its all-time high of $10.57 million, reached on March 31, 2022.
Performance
CAPR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CAPR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -620.6% | +5.3% | -8.4% |
| 3 y3 years | -154.6% | -68.7% | -848.4% |
| 5 y5 years | -84.7% | -68.7% | -848.4% |
CAPR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -620.6% | at low | -148.4% | +5.3% | -448.2% | at low |
| 5 y | 5-year | -620.6% | at low | -148.4% | +5.3% | -448.2% | at low |
| alltime | all time | -620.6% | at low | -148.4% | +5.3% | -448.2% | at low |
Capricor Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.64 M(-5.3%) | -$36.79 M(+8.4%) |
| Jun 2024 | - | -$12.29 M(+868.8%) | -$33.95 M(+9.2%) |
| Mar 2024 | - | -$1.27 M(-89.1%) | -$31.07 M(+21.4%) |
| Dec 2023 | -$25.60 M(-620.6%) | -$11.59 M(+31.8%) | -$25.60 M(+22.4%) |
| Sep 2023 | - | -$8.79 M(-6.6%) | -$20.90 M(+17.5%) |
| Jun 2023 | - | -$9.42 M(-323.7%) | -$17.80 M(+19.3%) |
| Mar 2023 | - | $4.21 M(-161.0%) | -$14.92 M(-403.5%) |
| Dec 2022 | $4.92 M(-129.2%) | -$6.90 M(+21.4%) | $4.92 M(-20.6%) |
| Sep 2022 | - | -$5.69 M(-13.1%) | $6.19 M(-27.5%) |
| Jun 2022 | - | -$6.54 M(-127.2%) | $8.54 M(-19.2%) |
| Mar 2022 | - | $24.05 M(-527.3%) | $10.57 M(-162.9%) |
| Dec 2021 | -$16.81 M(+67.2%) | -$5.63 M(+68.6%) | -$16.81 M(+11.9%) |
| Sep 2021 | - | -$3.34 M(-26.1%) | -$15.02 M(+2.5%) |
| Jun 2021 | - | -$4.51 M(+35.6%) | -$14.66 M(+20.5%) |
| Mar 2021 | - | -$3.33 M(-13.4%) | -$12.17 M(+21.0%) |
| Dec 2020 | -$10.05 M(+47.4%) | -$3.84 M(+29.0%) | -$10.05 M(+25.7%) |
| Sep 2020 | - | -$2.98 M(+47.6%) | -$8.00 M(+19.9%) |
| Jun 2020 | - | -$2.02 M(+65.5%) | -$6.67 M(+3.7%) |
| Mar 2020 | - | -$1.22 M(-31.8%) | -$6.43 M(-5.7%) |
| Dec 2019 | -$6.82 M(-50.8%) | -$1.78 M(+8.1%) | -$6.82 M(-22.6%) |
| Sep 2019 | - | -$1.65 M(-7.1%) | -$8.81 M(-13.1%) |
| Jun 2019 | - | -$1.78 M(+10.6%) | -$10.14 M(-15.9%) |
| Mar 2019 | - | -$1.61 M(-57.4%) | -$12.05 M(-13.1%) |
| Dec 2018 | -$13.86 M(-2.6%) | -$3.77 M(+26.5%) | -$13.86 M(+8.7%) |
| Sep 2018 | - | -$2.98 M(-19.2%) | -$12.76 M(-1.6%) |
| Jun 2018 | - | -$3.69 M(+8.0%) | -$12.97 M(-0.1%) |
| Mar 2018 | - | -$3.42 M(+28.1%) | -$12.97 M(-8.8%) |
| Dec 2017 | -$14.23 M(-1.5%) | -$2.67 M(-16.4%) | -$14.23 M(-5.4%) |
| Sep 2017 | - | -$3.19 M(-13.8%) | -$15.04 M(+9.3%) |
| Jun 2017 | - | -$3.70 M(-20.9%) | -$13.76 M(-7.9%) |
| Mar 2017 | - | -$4.68 M(+34.4%) | -$14.95 M(+3.4%) |
| Dec 2016 | -$14.45 M(+33.6%) | -$3.48 M(+82.0%) | -$14.45 M(-1.1%) |
| Sep 2016 | - | -$1.91 M(-60.9%) | -$14.62 M(-8.4%) |
| Jun 2016 | - | -$4.88 M(+16.8%) | -$15.95 M(+23.2%) |
| Mar 2016 | - | -$4.18 M(+14.8%) | -$12.95 M(+19.7%) |
| Dec 2015 | -$10.82 M(-1228.4%) | -$3.64 M(+12.3%) | -$10.82 M(+16.1%) |
| Sep 2015 | - | -$3.24 M(+72.8%) | -$9.32 M(+12.3%) |
| Jun 2015 | - | -$1.88 M(-8.5%) | -$8.30 M(-33.3%) |
| Mar 2015 | - | -$2.05 M(-4.4%) | -$12.44 M(-1397.4%) |
| Dec 2014 | $958.60 K(-115.6%) | -$2.15 M(-3.4%) | $958.60 K(-70.8%) |
| Sep 2014 | - | -$2.22 M(-63.1%) | $3.28 M(+230.2%) |
| Jun 2014 | - | -$6.02 M(-153.0%) | $994.80 K(-84.4%) |
| Mar 2014 | - | $11.34 M(+6208.7%) | $6.38 M(-203.8%) |
| Dec 2013 | -$6.14 M(+197.9%) | $179.80 K(-104.0%) | -$6.14 M(-4.5%) |
| Sep 2013 | - | -$4.51 M(+609.8%) | -$6.44 M(+166.1%) |
| Jun 2013 | - | -$635.70 K(-46.0%) | -$2.42 M(-8.2%) |
| Mar 2013 | - | -$1.18 M(+952.1%) | -$2.64 M(+27.8%) |
| Dec 2012 | -$2.06 M | -$111.80 K(-77.4%) | -$2.06 M(-41.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$494.70 K(-42.0%) | -$3.52 M(-4.3%) |
| Jun 2012 | - | -$852.80 K(+41.3%) | -$3.68 M(-7.9%) |
| Mar 2012 | - | -$603.50 K(-61.5%) | -$3.99 M(-14.1%) |
| Dec 2011 | -$4.65 M(+7.7%) | -$1.57 M(+140.4%) | -$4.65 M(+12.4%) |
| Sep 2011 | - | -$652.50 K(-44.1%) | -$4.14 M(-10.4%) |
| Jun 2011 | - | -$1.17 M(-7.4%) | -$4.62 M(+4.5%) |
| Mar 2011 | - | -$1.26 M(+19.4%) | -$4.42 M(+2.3%) |
| Dec 2010 | -$4.32 M(-25.5%) | -$1.06 M(-6.9%) | -$4.32 M(-1.5%) |
| Sep 2010 | - | -$1.13 M(+17.3%) | -$4.39 M(+4.3%) |
| Jun 2010 | - | -$966.70 K(-16.8%) | -$4.20 M(-17.0%) |
| Mar 2010 | - | -$1.16 M(+3.5%) | -$5.07 M(-12.6%) |
| Dec 2009 | -$5.80 M(-45.5%) | -$1.12 M(+17.8%) | -$5.80 M(-11.1%) |
| Sep 2009 | - | -$953.20 K(-47.9%) | -$6.52 M(-23.7%) |
| Jun 2009 | - | -$1.83 M(-3.3%) | -$8.54 M(-14.5%) |
| Mar 2009 | - | -$1.89 M(+2.3%) | -$9.99 M(-6.1%) |
| Dec 2008 | -$10.64 M(+98.0%) | -$1.85 M(-37.9%) | -$10.64 M(+1.8%) |
| Sep 2008 | - | -$2.98 M(-9.1%) | -$10.45 M(+11.4%) |
| Jun 2008 | - | -$3.27 M(+28.9%) | -$9.39 M(+35.1%) |
| Mar 2008 | - | -$2.54 M(+53.2%) | -$6.95 M(+29.3%) |
| Dec 2007 | -$5.37 M(+178.5%) | -$1.66 M(-13.1%) | -$5.37 M(-3.8%) |
| Sep 2007 | - | -$1.91 M(+128.7%) | -$5.59 M(+50.0%) |
| Jun 2007 | - | -$835.20 K(-13.7%) | -$3.72 M(+28.8%) |
| Mar 2007 | - | -$968.10 K(-48.3%) | -$2.89 M(+49.9%) |
| Dec 2006 | -$1.93 M(>+9900.0%) | -$1.87 M(+3827.9%) | -$1.93 M(+3202.7%) |
| Sep 2006 | - | -$47.70 K(+1973.9%) | -$58.40 K(+320.1%) |
| Jun 2006 | - | -$2300.00(-55.8%) | -$13.90 K(-5.4%) |
| Mar 2006 | - | -$5200.00(+62.5%) | -$14.70 K(-17.4%) |
| Dec 2005 | -$17.80 K(+14.8%) | -$3200.00(0.0%) | -$17.80 K(-7.3%) |
| Sep 2005 | - | -$3200.00(+3.2%) | -$19.20 K(-1.0%) |
| Jun 2005 | - | -$3100.00(-62.7%) | -$19.40 K(-9.3%) |
| Mar 2005 | - | -$8300.00(+80.4%) | -$21.40 K(+38.1%) |
| Dec 2004 | -$15.50 K(-25.5%) | -$4600.00(+35.3%) | -$15.50 K(+8.4%) |
| Sep 2004 | - | -$3400.00(-33.3%) | -$14.30 K(+5.9%) |
| Jun 2004 | - | -$5100.00(+112.5%) | -$13.50 K(-29.3%) |
| Mar 2004 | - | -$2400.00(-29.4%) | -$19.10 K(-8.2%) |
| Dec 2003 | -$20.80 K(+45.5%) | -$3400.00(+30.8%) | -$20.80 K(+7.2%) |
| Sep 2003 | - | -$2600.00(-75.7%) | -$19.40 K(-7.6%) |
| Jun 2003 | - | -$10.70 K(+161.0%) | -$21.00 K(-13.9%) |
| Mar 2003 | - | -$4100.00(+105.0%) | -$24.40 K(+69.4%) |
| Dec 2002 | -$14.30 K(+10.0%) | -$2000.00(-52.4%) | -$14.40 K(+10.8%) |
| Sep 2002 | - | -$4200.00(-70.2%) | -$13.00 K(+34.0%) |
| Jun 2002 | - | -$14.10 K(-339.0%) | -$9700.00(-446.4%) |
| Mar 2002 | - | $5900.00(-1083.3%) | $2800.00(-121.4%) |
| Dec 2001 | -$13.00 K(-65.1%) | -$600.00(-33.3%) | -$13.10 K(+4.8%) |
| Sep 2001 | - | -$900.00(-43.8%) | -$12.50 K(+7.8%) |
| Jun 2001 | - | -$1600.00(-84.0%) | -$11.60 K(+16.0%) |
| Mar 2001 | - | -$10.00 K | -$10.00 K |
| Dec 2000 | -$37.30 K(<-9900.0%) | - | - |
| Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Capricor Therapeutics?
- What is Capricor Therapeutics annual CFO year-on-year change?
- What is Capricor Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly CFO year-on-year change?
- What is Capricor Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Capricor Therapeutics?
- What is Capricor Therapeutics TTM CFO year-on-year change?
What is Capricor Therapeutics annual cash flow from operations?
The current annual CFO of CAPR is -$25.60 M
What is the all time high annual CFO for Capricor Therapeutics?
Capricor Therapeutics all-time high annual cash flow from operations is $4.92 M
What is Capricor Therapeutics annual CFO year-on-year change?
Over the past year, CAPR annual cash flow from operations has changed by -$30.51 M (-620.61%)
What is Capricor Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CAPR is -$11.64 M
What is the all time high quarterly CFO for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly cash flow from operations is $24.05 M
What is Capricor Therapeutics quarterly CFO year-on-year change?
Over the past year, CAPR quarterly cash flow from operations has changed by +$646.00 K (+5.26%)
What is Capricor Therapeutics TTM cash flow from operations?
The current TTM CFO of CAPR is -$36.79 M
What is the all time high TTM CFO for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM cash flow from operations is $10.57 M
What is Capricor Therapeutics TTM CFO year-on-year change?
Over the past year, CAPR TTM cash flow from operations has changed by -$2.85 M (-8.39%)